JPRN-jRCT1031220369招募中4 期
Prospective obsevational study in IgA nephropathy patients treated with dapahliflozin
Tomohito Gohda0 个研究点目标入组 150 人开始时间: 2022年10月7日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Diagnosis of IgA nephropathy by renal biopsy
- •(2) IgA nephropathy patients treated with dapagliflozin
- •(3) 20 years of age and older at the time of consent acquisition
- •(4) Receiving maximum tolerated dose of RAS inhibitors (excluding not tolerable case due to AE)
- •(5) After completion of predonine treatment
- •(6) eGFR more than 25 mL/min/1.73 m2
- •(7) Postive proteinuria
- •(8) Patients who have been fully informed about their participation in this study, and who have given their free and voluntary written consent based on a thorough understanding of the subject's own
排除标准
- •(1) Patients who are taking or may start steroids or other immunosuppressive drugs during the study period
- •(2) Patients who cannot walk on their own and need assistance or a wheelchair to get to the hospital
- •(3) Patients under treatment for malignant tumors
- •(4) BMI less than 18
- •(5) Other exclusion criteria include patients deemed inappropriate as research subjects by the principal investigator
- •A research subject is eligible if he/she meets all of the selection criteria and none of the exclusion criteria listed above
研究者
相似试验
招募中
不适用
Supplemental diagnostic methods of IgA nephropathy using morphological studies of urinary erythrocytes and tonsil biopsies in the patients with isolated hematuria.JPRN-UMIN000003844ational Defense Medical College30
招募中
不适用
The efficacy of supportive treatment in IgA nephropathyCTRI/2018/01/011414one
招募中
不适用
Effect of Immunosuppression in IgA nephropathyKCT0003039Yonsei University Health System, Severance Hospital172
终止
4 期
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive TreatmentIgANGlomerulonephritisNCT02523768Centre Hospitalier Universitaire de Saint Etienne117
尚未招募
不适用
Detection of risk factors for IgA nephritisIgA nephritisJPRN-UMIN000038058Department of Organ transplantation and General Surgery Kyoto Prefectural University of Medicine Kajii-cho 465, Kamigyo-ku, Kyoto, Japan100